Home/Filings/4/0001209191-22-058302
4//SEC Filing

THEUER CHARLES 4

Accession 0001209191-22-058302

CIK 0001394319other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 6:00 AM ET

Size

5.2 KB

Accession

0001209191-22-058302

Insider Transaction Report

Form 4
Period: 2022-11-18
THEUER CHARLES
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2022-11-18$1.41/sh+13,900$19,599310,118 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3992 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Issuer

Tracon Pharmaceuticals, Inc.

CIK 0001394319

Entity typeother

Related Parties

1
  • filerCIK 0001631338

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 6:00 AM ET
Size
5.2 KB